Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States

被引：0
|
作者：
Sunnie Kim
James E. Signorovitch
Hongbo Yang
Oscar Patterson-Lomba
Cheryl Q. Xiang
Brian Ung
Monika Parisi
John L. Marshall
机构：
[1] MedStar Georgetown University Hospital,Ruesch Center for the Cure of GI Cancers
[2] Analysis Group,undefined
[3] Inc.,undefined
[4] Celgene Corporation,undefined
[5] Georgetown University,undefined
[6] Lombardi Comprehensive Cancer Center,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Adverse events; FOLFIRINOX; Metastatic adenocarcinoma of the pancreas; nab-Paclitaxel; Real-world evidence; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1564 / 1577
页数：13
相关论文
共 50 条
  • [41] Second-line treatment of modified FOLFIRINOX or nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma
    Ozaka, Masato
    Sasaki, Takashi
    Yamada, Ikuhiro
    Kanata, Ryo
    Akiyama, Dai
    Katagiri, Tomoko
    Takano, Koichi
    Matsuyama, Masato
    Sasahira, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [42] A retrospective comparative study of S-IROX and modified FOLFIRINOX for patients with advanced pancreatic cancer refractory to gemcitabine plus nab-paclitaxel
    Kei Saito
    Yousuke Nakai
    Naminatsu Takahara
    Kazunaga Ishigaki
    Yukari Suzuki
    Akiyuki Inokuma
    Kensaku Noguchi
    Sachiko Kanai
    Tatsuya Sato
    Ryunosuke Hakuta
    Tomotaka Saito
    Tsuyoshi Hamada
    Suguru Mizuno
    Hirofumi Kogure
    Hideaki Ijichi
    Keisuke Tateishi
    Kazuhiko Koike
    Investigational New Drugs, 2021, 39 : 605 - 613
  • [43] Nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreatic cancer: our experience
    Mare, M.
    Munao, S.
    Germana, S.
    Colarossi, C.
    Sciacca, D.
    Giuffrida, D.
    Giannone, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [44] NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
    Nichetti, Federico
    Rota, Simone
    Ambrosini, Paolo
    Pircher, Chiara
    Gusmaroli, Eleonora
    Busset, Michele Droz Dit
    Pusceddu, Sara
    Sposito, Carlo
    Coppa, Jorgelina
    Morano, Federica
    Pietrantonio, Filippo
    Di Bartolomeo, Maria
    Mariani, Luigi
    Mazzaferro, Vincenzo
    de Braud, Filippo
    Niger, Monica
    JAMA NETWORK OPEN, 2024, 7 (01)
  • [45] Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine
    Di Costanzo, Francesco
    Di Costanzo, Federica
    Antonuzzo, Lorenzo
    Mazza, Ernesto
    Giommoni, Elisa
    CANCERS, 2023, 15 (02)
  • [46] Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
    Sawada, Masashi
    Kasuga, Akiyoshi
    Mie, Takafumi
    Furukawa, Takaaki
    Taniguchi, Takanobu
    Fukuda, Koshiro
    Yamada, Yuto
    Takeda, Tsuyoshi
    Kanata, Ryo
    Matsuyama, Masato
    Sasaki, Takashi
    Ozaka, Masato
    Sasahira, Naoki
    BMC CANCER, 2020, 20 (01)
  • [47] Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
    Masashi Sawada
    Akiyoshi Kasuga
    Takafumi Mie
    Takaaki Furukawa
    Takanobu Taniguchi
    Koshiro Fukuda
    Yuto Yamada
    Tsuyoshi Takeda
    Ryo Kanata
    Masato Matsuyama
    Takashi Sasaki
    Masato Ozaka
    Naoki Sasahira
    BMC Cancer, 20
  • [48] FOLFIRINOX versus gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer: a single-center cohort study
    Cho, I.
    Kang, H.
    Jo, J.
    Lee, H.
    Chung, M.
    Park, J.
    Park, S.
    Song, S.
    Park, M.
    An, C.
    Jung, S.
    Bang, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [49] A systemic review and meta-analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel in the neoadjuvant treatment of localized pancreatic cancer.
    Fatima, Zainab
    Alhabhbeh, Ammar
    Darweesh, Mohammad
    Laswi, Hisham
    Manthri, Sukesh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16272 - E16272
  • [50] Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System
    Patel, Timil
    Miccio, Joseph
    Cecchini, Michael
    Srikumar, Thejal
    Stein, Stacey
    Kortmanksy, Jeremy
    Johung, Kimberly
    Lacy, Jill
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (06) : 2547 - 2556
12345